Is There a Future for Biopharmaceutical Value-Based Contracting?
ISPOR—The Professional Society for Health Economics and Outcomes ResearchValue in Health announced today the publication of a series of articles providing perspectives on biopharmaceutical value-based contracting and what the future may hold for risk-sharing arrangements.